95 related articles for article (PubMed ID: 8028752)
1. [The clinical usefulness of tumor markers in thyroid neoplastic pathology. Our experience].
Gerardi G; De Angelis P
Minerva Med; 1994 May; 85(5):237-40. PubMed ID: 8028752
[TBL] [Abstract][Full Text] [Related]
2. The role of estimation of the ratio of preoperative serum thyroglobulin to the thyroid mass in predicting the behaviour of well differentiated thyroid cancers.
Sharma AK; Sarda AK; Chattopadhyay TK; Kapur MM
J Postgrad Med; 1996; 42(2):39-42. PubMed ID: 9715297
[TBL] [Abstract][Full Text] [Related]
3. Value of serum thyroglobulin measurement in patients operating on for well differentiated thyroid carcinoma.
Rüter A; Smeds S; Lennquist S
Eur J Surg; 1998 Sep; 164(9):665-71. PubMed ID: 9728785
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
[TBL] [Abstract][Full Text] [Related]
5. [Tumor markers for endocrine neoplasms].
Okamoto T
Gan To Kagaku Ryoho; 2001 Apr; 28(4):561-5. PubMed ID: 11329795
[TBL] [Abstract][Full Text] [Related]
6. [The significance of thyroglobulin determination in the follow-up of patients with papillary or follicular thyroid carcinoma].
Hennemann G; Hennemann IP; Docter R; Krenning EP
Ned Tijdschr Geneeskd; 1989 Mar; 133(10):491-3. PubMed ID: 2651932
[No Abstract] [Full Text] [Related]
7. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
8. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
9. [Differentiated thyroid cancers].
Gorgone S; Campennì A; Calbo E; Catalfamo A; Sciglitano P; Sofia L; Niceta M; Borzì R; Calbo L
G Chir; 2009; 30(1-2):26-9. PubMed ID: 19272228
[TBL] [Abstract][Full Text] [Related]
10. [A case with poorly differentiated follicular carcinoma of the thyroid produced and secreted CEA].
Kobayashi K; Yokozawa T; Ito Y; Matsuzuka H; Kuma K; Miyauchi A; Kakudo K
Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):488-90. PubMed ID: 12854498
[TBL] [Abstract][Full Text] [Related]
11. [Thyroid carcinoma].
Tamaki H
Gan To Kagaku Ryoho; 2005 Apr; 32(4):561-5. PubMed ID: 15853229
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
[TBL] [Abstract][Full Text] [Related]
13. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas.
Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF
J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907
[TBL] [Abstract][Full Text] [Related]
14. Anti-thyroglobulin antibodies in differentiated thyroid carcinoma patients: Study of the clinical and biological parameters.
Rahmoun MN; Bendahmane I
Ann Endocrinol (Paris); 2014 Feb; 75(1):15-8. PubMed ID: 24560398
[TBL] [Abstract][Full Text] [Related]
15. Thyroglobulin monitoring after treatment of well-differentiated thyroid cancer.
Hamy A; Mirallié E; Bennouna J; Resche I; Drefty C; Johnstone M; Visset J
Eur J Surg Oncol; 2004 Aug; 30(6):681-5. PubMed ID: 15256244
[TBL] [Abstract][Full Text] [Related]
16. Postsurgical management of differentiated thyroid carcinoma.
Mazzaferri EL; Robyn J
Otolaryngol Clin North Am; 1996 Aug; 29(4):637-62. PubMed ID: 8844735
[TBL] [Abstract][Full Text] [Related]
17. Serum cytokeratins determination in differentiated thyroid carcinoma.
Appetecchia M; Meçule A; Ducci M; Palma L; Castelli M
J Exp Clin Cancer Res; 2001 Jun; 20(2):253-6. PubMed ID: 11484983
[TBL] [Abstract][Full Text] [Related]
18. [Trends of thyroid pathology in a referral center: steady prevalence of papillary thyroid carcinoma but goiter increase in thyroidectomies].
Gamboa-Domínguez A; Lino-Silva S; Candanedo-González F; Medina-López E; Acuña-González D; Jacinto-Cortés I; González-Treviño O
Rev Invest Clin; 2011; 63(2):148-54. PubMed ID: 21717721
[TBL] [Abstract][Full Text] [Related]
19. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study on the treatment of differentiated carcinoma of the thyroid gland].
Francomano F; Napolitano L; De Luca D; Scipione P; Napolitano AM
G Chir; 1999; 20(1-2):31-3. PubMed ID: 10097453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
